SBIR-STTR Award

Kits for 3-Dimensional Histophysiologic Gradient Culture
Award last edited on: 3/3/02

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$98,417
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Joseph Leighton

Company Information

Aeron Biotechnology Inc

1933 Davis Street Suite 310
San Leandro, CA 94577
   (510) 729-0382
   aeron@aeron.com
   www.aeron.com
Location: Single
Congr. District: 13
County: Alameda

Phase I

Contract Number: 1R43CA068873-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1995
Phase I Amount
$98,417
We will develop a commercial kit so that biologists can readily study tissues under conditions of histophysiologic gradient culture. Here, as in nature, stratified epithelia adhere to their supporting stroma at a recognizable interface. Renewal of epithelium occurs adjacent to the interface, and all metabolic exchange is by diffusion across the interface. In culture, a thin, transparent, permeable collagen membrane serves as a "stroma." Cells attach to one surface of the membrane, the medium bathes the opposite side, and metabolic exchange for the cells is by diffusion across the collagen. The side of the membrane in contract with the cells is waffled with collagen, which increases the tensile strength of the membrane and the surface area for cell attachment. The membrane is used in two configurations, as a flat substrate, and as a thin cylindrical chamber closed at both ends. With commercial kits available, a number of basic and clinical biomedical applications will follow. Processes of tissue remodeling, aging, metaplasia,atrophy, hypertrophy, dysplasia, carcinogenesis, intra-epithelial invasion, and viral propagation can be reconstituted and manipulated. Clinical applications are numerous too, both in diagnosis and treatment,e.g. characterization of cells from a biopsy that will predict the subsequent course.National Cancer Institute (NCI)

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----